| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1977PNAS...74.3090H |
| P356 | DOI | 10.1073/PNAS.74.7.3090 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC431419 |
| https://europepmc.org/articles/PMC431419?pdf=render | ||
| https://pnas.org/doi/pdf/10.1073/pnas.74.7.3090 | ||
| P932 | PMC publication ID | 431419 |
| P698 | PubMed publication ID | 268657 |
| P5875 | ResearchGate publication ID | 22868163 |
| P50 | author | Stuart Bevan | Q43092274 |
| P2093 | author name string | S. Heinemann | |
| J. Lindstrom | |||
| J. Rice | |||
| R. Kullberg | |||
| P2860 | cites work | Voltage clamp analysis of acetylcholine produced end-plate current fluctuations at frog neuromuscular junction | Q24538986 |
| Thyrotropin-releasing hormone regulates the number of its own receptors in the GH3 strain of pituitary cells in culture | Q28320267 | ||
| Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value | Q34068275 | ||
| Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites | Q34505907 | ||
| Voltage-dependence of drug-induced conductance in frog neuromuscular junction | Q35081095 | ||
| Rapid changes in rat pineal beta-adrenergic receptor: alterations in l-(3H)alprenolol binding and adenylate cyclase | Q35089912 | ||
| Acetylcholine receptor turnover in membranes of developing muscle fibers | Q36196942 | ||
| Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automim | Q36359829 | ||
| Nerve-muscle interaction in vitro. Role of acetylcholine | Q36428840 | ||
| Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. | Q37428285 | ||
| Appearance of Acetylcholine Receptors During Differentiation of a Myogenic Cell Line | Q37495848 | ||
| Acetylcholine Receptors of Muscle Grown In Vitro | Q37498966 | ||
| Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction | Q39323918 | ||
| Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis | Q39342356 | ||
| An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis | Q39995150 | ||
| Loss of alpha-bungarotoxin from junctional and extrajunctional acetylcholine receptors in rat diaphragm muscle in vivo and in organ culture | Q41074116 | ||
| Characterization of a unique muscle cell line | Q41187169 | ||
| Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles | Q41773693 | ||
| Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects | Q44518936 | ||
| Modulation of TL (thymus-leukemia) antigens by Fab-fragments of TL antibody | Q45011824 | ||
| End-plate potentials in experimental autoimmune myasthenia gravis in rats | Q45225464 | ||
| Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors | Q47957752 | ||
| AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS. | Q52762374 | ||
| Influence of Denervation on Localization of Neurotoxins from Clapid Venoms in Rat Diaphragm | Q59041275 | ||
| Turnover of junctional and extrajunctional acetylcholine receptors of the rat diaphragm | Q66910835 | ||
| Acetylcholine receptors in normal and denervated rat diaphragm muscle. II. Comparison of junctional and extrajunctional receptors | Q66954541 | ||
| Reduced muscle acetylcholine sensitivity in rats immunised with acetylcholine receptor | Q67440667 | ||
| Kinetics of biosynthesis of acetylcholine receptor and subsequent incorporation into plasma membrane of cultured chick skeletal muscle | Q67555587 | ||
| Acetylcholine receptor metabolism in a nonfusing muscle cell line | Q67556564 | ||
| Acetylcholine receptor degradation measured by pulse chase labelling | Q68217999 | ||
| Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors | Q68809008 | ||
| Antibody-induced changes in expression of the H-2 antigen | Q68819802 | ||
| The statistical nature of the acetylcholine potential and its molecular components | Q70478626 | ||
| The action of tubocurarine and atropine on the normal and denervated rat diaphragm | Q72258109 | ||
| THE DEVELOPMENT OF ACETYLCHOLINE SENSITIVITY IN NERVE-FREE SEGMENTS OF SKELETAL MUSCLE | Q76849791 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 3090-3094 | |
| P577 | publication date | 1977-07-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Modulation of acetylcholine receptor by antibody against the receptor | |
| P478 | volume | 74 |
| Q50327901 | A New Classification System for IgG4 Autoantibodies |
| Q66971856 | A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis |
| Q70870998 | A new mechanism revealed for the action of antibodies on acetylcholine receptor function |
| Q67018275 | A possible modulation of acetylcholine receptors of embryonic chick muscle cells by α-bungarotoxin |
| Q72869173 | A post-natal decrease in acetylcholine channel open time at rat end-plates |
| Q39934213 | A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines |
| Q70577979 | Acetylcholine receptor and thymus in experimental autoimmune myasthenia gravis and experimental myositis |
| Q41632661 | Acetylcholine receptor in rabbit thymus: antigenic similarity between acetylcholine receptors of muscle and thymus |
| Q42581479 | Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis |
| Q67726583 | Acetylcholine receptor-reactive antibodies in experimental autoimmune myasthenia gravis differing in disease-causing potential: Subsetting of serum antibodies by preparative isoelectric focusing |
| Q36205703 | Acetylcholine receptor: effects of proteolysis on receptor metabolism |
| Q33862589 | Acetylcholine receptors and myasthenia |
| Q44975152 | Acetylcholine-induced conductance fluctuations in cultured human myotubes |
| Q33744105 | Acquired myasthenia gravis: what we have learned from experimental and spontaneous animal models |
| Q44014466 | Action of antibodies directed against the acetylcholine receptor on channel function at mouse and rat motor end-plates |
| Q36223736 | Agrin-induced reorganization of extracellular matrix components on cultured myotubes: relationship to AChR aggregation |
| Q55652924 | Anti-acetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis. |
| Q36399303 | Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors |
| Q67344918 | Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle |
| Q66965948 | Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis |
| Q40279136 | Antiserum against rat luteinizing hormone (LH) receptors |
| Q90312411 | Autoantibodies in Neuropsychiatric Disorders |
| Q37315963 | Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity |
| Q38710287 | Autoimmune synaptopathies |
| Q36405699 | Carbohydrate requirement for expression and stability of acetylcholine receptor on the surface of embryonic muscle cells in culture |
| Q41077570 | Cellular mechanisms of adaptation of grafts to antibody |
| Q39854787 | Chapter 13 Antibody Effects on Membrane Antigen Expression |
| Q43916530 | Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient. |
| Q70766574 | Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG) |
| Q34948013 | Cholesterol modulates the rate and mechanism of acetylcholine receptor internalization |
| Q38323531 | Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor |
| Q52298946 | Contribution of cholinesterase to developmental decreases in the time course of synaptic potentials at an amphibian neuromuscular junction |
| Q68952443 | Decrease in acetylcholine-receptor content of human myotube cultures mediated by monoclonal antibodies to alpha, beta and gamma subunits |
| Q41431238 | Degradation of acetylcholine receptors in muscle cells: effect of leupeptin on turnover rate, intracellular pool sizes, and receptor properties |
| Q36200908 | Dispersal and reformation of acetylcholine receptor clusters of cultured rat myotubes treated with inhibitors of energy metabolism |
| Q69429792 | Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate |
| Q41492440 | Effects of antibodies to Torpedo acetylcholine receptor on the acetylcholine receptor-lonic channel complex of Torpedo electroplax and rabbit intercostal muscle |
| Q40259101 | Effects of myasthenic immunoglobulins and of prednisolone on spontaneous miniature end-plate potentials in mouse diaphragms |
| Q37000263 | Experimental autoimmune myasthenia gravis |
| Q44308219 | Experimental autoimmune myasthenia gravis in mice expressing human immunoglobulin loci |
| Q36343285 | Experimental myasthenia gravis. A murine system |
| Q36532847 | Extracellular synaptic factors induce clustering of acetylcholine receptors stably expressed in fibroblasts |
| Q36220753 | Fibroblasts transfected with Torpedo acetylcholine receptor beta-, gamma-, and delta-subunit cDNAs express functional receptors when infected with a retroviral alpha recombinant |
| Q41499110 | Functional consequences of agonist-mediated state transitions in the cholinergic receptor. Studies in cultured muscle cells |
| Q46066550 | Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera. |
| Q90577074 | Glycine receptor autoantibodies disrupt inhibitory neurotransmission |
| Q38323537 | High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor |
| Q33681420 | Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys |
| Q37399650 | Human systemic lupus erythematosus sera contain antibodies against cell-surface protein(s) that share(s) epitope(s) with DNA. |
| Q38182086 | Humoral pathogenesis of myasthenia gravis |
| Q33961390 | Immunization of rats with polypeptide chains from torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle |
| Q34172055 | Immunochemical and molecular characterization of anti-RNA polymerase I autoantibodies produced by tight skin mouse |
| Q35058992 | Immunological distinction between acetylcholine receptor and the alpha-bungarotoxin-binding component on sympathetic neurons |
| Q38153563 | Immunopathologic events at the endplate in myasthenia gravis |
| Q37610782 | In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor |
| Q68094987 | Increased levels of acetylcholine receptor alpha-subunit mRNA in experimental autoimmune myasthenia gravis |
| Q67391887 | Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells |
| Q73077132 | Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies |
| Q39237519 | Mechanisms of acetylcholine receptor loss in myasthenia gravis |
| Q36219579 | Metabolic stability and antigenic modulation of nicotinic acetylcholine receptors on bovine adrenal chromaffin cells |
| Q67344915 | Modulation of acetylcholine receptor in rat diaphragm by anti-receptor sera |
| Q71310685 | Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia |
| Q70176476 | Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballs |
| Q36355014 | Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits |
| Q46428223 | Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity |
| Q91588676 | Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture |
| Q93537362 | Myasthenia gravis |
| Q39912959 | Myasthenia gravis, the acetylcholine receptor and the immune response |
| Q34192385 | Myasthenia gravis--current concepts. |
| Q40487612 | Myasthenia gravis: An autoimmune response against the acetylcholine receptor |
| Q42665358 | Neuromuscular Transmission in experimental autoimmune myasthenia gravis (EAMG). Quantitative ionophoresis and current fluctuation analysis at normal and myasthenic rat end-plates |
| Q39536315 | No Significant Correlation of HLA-B8 and Amount of Antibodies Directed to Acetylcholine Receptor Protein in Patients with Myasthenia Gravis |
| Q68033058 | Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor |
| Q72885517 | Plasma exchange in myasthenia gravis: Electrophysiological studies |
| Q34619716 | Presence of antibodies against a cell-surface protein, cross-reactive with DNA, in systemic lupus erythematosus: a marker of the disease |
| Q57985839 | Properties of end-plate channels in rats immunized against acetylcholine receptors |
| Q41137370 | Rapsyn and agrin slow the metabolic degradation of the acetylcholine receptor |
| Q72872035 | Receptor stability and channel conversion in the subsynaptic membrane of the developing mammalian neuromuscular junction |
| Q34612779 | Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis |
| Q37591281 | Regulation of acetylcholine receptor levels by a cholinergic agonist in mouse muscle cell cultures |
| Q34612356 | Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development |
| Q67734481 | Repetitive nerve stimulation vs. twitch tension in rats with EAMG |
| Q41640842 | Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis |
| Q36340160 | Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis |
| Q72385643 | Single acetylcholine-activated channel currents in developing muscle cells |
| Q39545617 | Specificities of antibodies to acetylcholine receptors |
| Q36275255 | Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies |
| Q71523439 | Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis |
| Q39290249 | Specificities of autoantibodies in autoimmune receptor diseases |
| Q71012142 | Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis |
| Q40844250 | Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR. |
| Q37727984 | The auto-antigen repertoire in myasthenia gravis. |
| Q39796829 | The effects of innervation on the properties of acetylcholine receptors in muscle |
| Q48119775 | The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis |
| Q40693250 | The immunopathology of myasthenia gravis |
| Q36719645 | The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies |
| Q36690423 | The main immunogenic region of the acetylcholine receptor. Structure and role in myasthenia gravis |
| Q38070762 | The search for new antigenic targets in myasthenia gravis |
| Q71278013 | The use of antibodies in neuroscience. Effects of antibodies against acetylcholine receptor and acetylcholinesterase |
| Q31965819 | Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis |
| Q73738660 | Treatment of passively transferred experimental autoimmune myasthenia gravis using papain |
Search more.